These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1046 related items for PubMed ID: 9886762

  • 41. Improved n-3 fatty acid status does not modulate insulin resistance in fa/fa Zucker rats.
    Gillam M, Noto A, Zahradka P, Taylor CG.
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):331-9. PubMed ID: 19864121
    [Abstract] [Full Text] [Related]

  • 42. Sex-dependent hepatic transcripts and metabolites in the development of glucose intolerance and insulin resistance in Zucker diabetic fatty rats.
    Gustavsson C, Soga T, Wahlström E, Vesterlund M, Azimi A, Norstedt G, Tollet-Egnell P.
    J Mol Endocrinol; 2011 Oct; 47(2):129-43. PubMed ID: 21673048
    [Abstract] [Full Text] [Related]

  • 43. Pioglitazone treatment for 7 days failed to correct the defect in glucose transport and glucose transporter translocation in obese Zucker rat (fa/fa) skeletal muscle plasma membranes.
    Hirshman MF, Fagnant PM, Horton ED, King PA, Horton ES.
    Biochem Biophys Res Commun; 1995 Mar 17; 208(2):835-45. PubMed ID: 7695642
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Postprandial insulin resistance in Zucker diabetic fatty rats is associated with parasympathetic-nitric oxide axis deficiencies.
    Afonso RA, Fernandes AB, Santos C, Ligeiro D, Ribeiro RT, Lima IS, Patarrao RS, Videira PA, Caldeira J, Macedo MP.
    J Neuroendocrinol; 2012 Oct 17; 24(10):1346-55. PubMed ID: 22672343
    [Abstract] [Full Text] [Related]

  • 47. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y, Taketomi S, Shimura Y, Ikeda H, Fujita T.
    Arzneimittelforschung; 1990 Mar 17; 40(3):263-7. PubMed ID: 2189419
    [Abstract] [Full Text] [Related]

  • 48. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats.
    Liu X, Pérusse F, Bukowiecki LJ.
    Am J Physiol; 1998 May 17; 274(5):R1212-9. PubMed ID: 9644032
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Metformin and liver glycogen synthase activity in obese Zucker rats.
    Huupponen R, Pyykkö K, Koulu M, Rouru J.
    Res Commun Chem Pathol Pharmacol; 1993 Feb 17; 79(2):219-27. PubMed ID: 8451543
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Potent antidiabetic effects of rivoglitazone, a novel peroxisome proliferator-activated receptor-gamma agonist, in obese diabetic rodent models.
    Kanda S, Nakashima R, Takahashi K, Tanaka J, Ogawa J, Ogata T, Yachi M, Araki K, Ohsumi J.
    J Pharmacol Sci; 2009 Oct 17; 111(2):155-66. PubMed ID: 19809220
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.
    Pickavance LC, Brand CL, Wassermann K, Wilding JP.
    Br J Pharmacol; 2005 Feb 17; 144(3):308-16. PubMed ID: 15655531
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats.
    Agil A, Navarro-Alarcón M, Ruiz R, Abuhamadah S, El-Mir MY, Vázquez GF.
    J Pineal Res; 2011 Mar 17; 50(2):207-12. PubMed ID: 21087312
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.